Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,200 | -56,147 | -41,358 | -27,529 | -16,099 |
| Depreciation Amortization | 459 | 2,689 | 2,011 | 1,056 | 516 |
| Accounts receivable | N/A | 886 | 886 | 886 | 886 |
| Accounts payable and accrued liabilities | -1,046 | 333 | 166 | -334 | 1,610 |
| Other Working Capital | 145 | -756 | -775 | -1,131 | 1,781 |
| Other Operating Activity | 4,658 | 7,574 | 5,847 | 3,814 | -511 |
| Operating Cash Flow | $-12,984 | $-45,421 | $-33,223 | $-23,238 | $-11,817 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 25,599 | -121,188 | -155,977 | -158,788 | -138,591 |
| PPE Investments | -216 | -1,016 | -918 | -732 | -263 |
| Investing Cash Flow | $25,383 | $-122,204 | $-156,895 | $-159,520 | $-138,854 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 100 | N/A | 0 | N/A | 0 |
| Common Stock Issued | 70,499 | 17,061 | 395 | 342 | 187 |
| Other Financing Activity | -801 | -313 | -292 | 0 | 0 |
| Financing Cash Flow | $69,798 | $16,748 | $103 | $342 | $187 |
| Exchange Rate Effect | N/A | -774 | -442 | -231 | -117 |
| Beginning Cash Position | 70,519 | 222,170 | 222,170 | 222,170 | 222,170 |
| End Cash Position | 152,716 | 70,519 | 31,713 | 39,523 | 71,569 |
| Net Cash Flow | $82,197 | $-151,651 | $-190,457 | $-182,647 | $-150,601 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,984 | -45,421 | -33,223 | -23,238 | -11,817 |
| Capital Expenditure | -216 | -1,016 | -918 | -732 | -263 |
| Free Cash Flow | -13,200 | -46,437 | -34,141 | -23,970 | -12,080 |